Bleomycin
Therapeutic Indications
Bleomycin is indicated for:
Hodgkin's lymphoma
Irrespective of gender only Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intramuscular - 5,000-15,000 IU/m² once or twice a week
Treatment 2: Intravenous - 5,000-15,000 IU/m² once or twice a week
Non-Hodgkin's lymphoma
Irrespective of gender only Adults (18 years old or older)
Non-Hodgkin’s lymphoma of intermediate and high malignancy in adults.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intramuscular - 5,000-15,000 IU/m² once or twice a week
Treatment 2: Intravenous - 5,000-15,000 IU/m² once or twice a week
Squamous cell carcinoma (SCC) of the head and neck, cervix, external genitalia
Irrespective of gender only Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intramuscular - 10,000-15,000 IU/m² once or twice a week every 3-4 weeks
Treatment 2: Intravenous - 10,000-15,000 IU/m² once or twice a week every 3-4 weeks
Malignant pleural effusion
Irrespective of gender only Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intrapleural - 60,000 IU
Testicular carcinoma (seminoma and non-seminoma)
Men inly, only Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intramuscular - 10,000-15,000 IU/m² once or twice a week every 3-4 weeks
Treatment 2: Intravenous - 10,000-15,000 IU/m² once or twice a week every 3-4 weeks
Treatment 3: Intravenous - 10,000-15,000 IU/m² once a day for 5-6 consecutive days every 3-4 weeks
Contraindications
Active ingredient Bleomycin is contraindicated in the following cases:
Lactation
No gender/age discrimination
It is unknown if bleomycin or the metabolites are excreted in the mother’s milk. Due to possible very harmful effects on the infant, breast-feeding during treatment with bleomycin is contraindicated.
Pulmonary infection, severely impaired lung function
No gender/age discrimination
Ataxia-telangiectasia
No gender/age discrimination